Industry Alliance Office
The Industry Alliance Office acting on behalf of Amsterdam Neuroscience is a full service shop to the pharma- and biotech-industry for basic and translational neuroscience, but also for clinical trials all the way up to phase III. Since 2013 the IAO has
commercialized the scientific excellence, research assets, access to patient cohorts and material, and infrastructure based on a disease-orientated approach: Neurodegeneration (AD, FTD, Lewy Body Dementia and Vascular Cognitive Impairment), Neuro-inflammation (MS), Neuro-infection (Meningitis, Chronic Inflammatory Demyelinating Polyneuropathy), Neurovascular Disorders and Neuropsychiatry (Anxiety and Depression, Psychosis, OCD, PTSD and SZ). In 2018 we have upscaled this embedded business development activity to include the entire Amsterdam Neursocience community.